Cytokine Storm / Immune response signaling
Cytokine storm describes an excessive immune response to external stimuli with the release of a large amount of pro-inflammatory cytokines. Cytokine storms occur in a range of infections and non-infectious diseases including COVID-19. The cytokine storm involves a variety of immune-related molecules such as interferon, interleukins, chemokines, CSFs and TNF-α. Increase in proinflammatory cytokines results in an influx of immune cells such as macrophages, T-Cells and neutrophils. The immune response to SARS-CoV2 infection also involves various signaling pathways. Researchers can save up to 50% on small molecules that affect cytokine storm and the immune response, as they are up to half the price of other suppliers.
View products: Angiotensin related | Cytokines, chemokines & NF-κB/I-κB | Inflammasomes | JAK/STAT | MAPK Signaling | PI3K/Akt/mTOR | Protease-Activated Receptors | TLR signaling
- Description:
Phosphatase Inhibitor Cocktail solution for use in cell lysates and tissue extracts including samples containing detergents.
- Description:
Phosphatase Inhibitor Cocktail solution (with Calyculin A) for the inhibition of serine/threonine and alkaline phosphatases.
- Description:
Protease & Phosphatase Inhibitor Cocktail solution (EDTA free)
- Description:
Protease & Phosphatase Inhibitor Cocktail solution (plus EDTA)
- Description:
Protease Inhibitor Cocktail powder for general use to inhibit a broad range of proteases and esterases
- Description:
Protease Inhibitor Cocktail (EDTA free) solution for mammalian cell and tissue extract use
- Description:
Protease Inhibitor Cocktail (EDTA free) solution for plant cell and tissue extract use
PS-341 [Bortezomib] (HB4036)
Description:Highly potent, selective, reversible and cell permeable proteasome inhibitor
Purity:>98%
-
Q-VD-OPh (HB4048)
Description:Cell permeable, irreversible and non-toxic pan-caspase inhibitor
Purity:>95%
![PS-341 [Bortezomib]](https://hellobio.com/media/catalog/product/cache/7630ee9852b6c22c7de1165054afc779/p/s/ps-341_bortezomib_hb4036_product_vial_image.jpg)